UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
1.
7 p, 254.5 KB Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics : Results From a Cross-Sectional Study / Fernández-Carballido, Cristina (Hospital Universitario San Juan de Alicante) ; Martín-Martínez, María A. (Sociedad Española de Reumatología) ; García-Gómez, Carmen (Consorci Sanitari de Terrassa) ; Castañeda, Santos (Hospital Universitario de la Princesa (Madrid)) ; González-Juanatey, Carlos (Hospital Universitario Lucus Augusti (Lugo)) ; Sánchez-Alonso, Fernando (Sociedad Española de Reumatología) ; García de Vicuña, Rosario (IIS-IP) ; Erausquin-Arruabarrena, Celia (Hospital Universitario de Gran Canaria Dr. Negrín) ; López-Longo, Javier (Hospital General Universitario Gregorio Marañón) ; Sánchez, María D. (Hospital Universitario Clínico) ; Corrales, Alfonso (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Quesada-Masachs, Estefanía (Hospital Universitari Vall d'Hebron) ; Chamizo, Eugenio (Hospital Universitario de Mérida) ; Barbadillo, Carmen (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Bachiller-Corral, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ; Cobo-Ibañez, Tatiana (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Turrión, Ana (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Giner, Emilio (Hospital Obispo Polanco) ; Llorca, Javier (Universidad de Cantabria) ; Gonzalez-Gay, MA (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
To evaluate the impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). This was a cross-sectional analysis of the baseline visit from the Cardiovascular in Rheumatology study. [...]
2020 - 10.1002/acr.23910
Arthritis Care & Research, Vol. 72 (may 2020) , p. 822-828  
2.
11 p, 255.5 KB Maintenance of clinical efficacy and radiographic benefit through two years of ustekinumab therapy in patients with active psoriatic arthritis : results from a randomized, placebo-controlled phase III trial / Kavanaugh, Arthur (University of California) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Gottlieb, Alice B. (Tufts Medical Center) ; Ritchlin, Christopher (University of Rochester) ; Li, Shu (Janssen Pharmaceutica) ; Wang, Yuhua (Janssen Pharmaceutica) ; Mendelsohn, Alan M. (Janssen Pharmaceutica) ; Song, Michael (Janssen Pharmaceutica) ; Zhu, Yaowei (Janssen Pharmaceutica) ; Rahman, Proton (Memorial University of Newfoundland) ; McInnes, Iain B. (University of Glasgow) ; Universitat Autònoma de Barcelona
To evaluate the efficacy and safety of ustekinumab through 2 years in adult patients with active psoriatic arthritis (PsA). A total of 615 adult patients with active PsA were randomized to placebo, ustekinumab 45 mg, or ustekinumab 90 mg, at weeks 0, 4, and every 12 weeks through week 88 (last dose). [...]
2015 - 10.1002/acr.22645
Arthritis Care & Research, Vol. 67, issue 12 (Dec. 2015) , p. 1739-1749  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.